Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors
marketwatch.com
news
2022-06-02 20:45:00

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP, +1.50% shed 2.03% to $0.29 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, -1.89% rising 2.69% to 12,316.90 and the Dow Jones Industrial Average DJIA, -0.63% rising 1.33% to 33,248.28. This was the stock's second consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $2.00 short of its 52-week high ($2.29), which the company reached on June 9th. The stock underperformed when compared to some of its competitors Thursday, as Fate Therapeutics Inc.
